| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6201298 | Ophthalmology | 2014 | 18 Pages |
Abstract
In ranibizumab treatment for patients with AMD, a possible relationship of more intensive treatment to more systemic vascular adverse events was identified, but no relationship with mortality was identified.
Keywords
FDAPDTAMDCVAPRNATEMedDRAMyocardial infarctionUS Food and Drug AdministrationPhotodynamic therapyMedical Dictionary for Regulatory Activitiesarterial thromboembolic eventage-related macular degenerationCerebrovascular accidentVascular endothelial growth factorVascular Endothelial Growth Factor (VEGF)odds ratio
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Takashi MD, PhD, Yasuo MD, Taku MD, Takuhiro PhD, Shiro MD, PhD,